JAN 30, 2017 7:22 PM PST

Flu Shot For Fido

WRITTEN BY: Kara Marker

You’re not the only one who needs to head to the clinic this flu season; your dog might need to pay a visit as well! Yes, dogs can fall victim to the influenza virus just like humans, pigs, birds, and other animals.

There are specific strains that exist among dogs, but they could pass to humans in the future, experts say. To ward off a potentially dangerous “dog flu,” scientists from the University of Rochester introduce a new type of live-attenuated flu vaccine.

It's that dreaded time of year -- flu season. And we humans aren't the only ones feeling the pain. Dogs can get the flu, too. Scientists have developed, for the first time, two new vaccines for canine influenza. Source: University of Rochester School of Medicine and Dentistry

A live-attenuated vaccine contains a weakened virus that, while still alive, triggers an immune response without actually causing illness. On the other hand, inactivated vaccines contain no live virus, only pieces of it that trigger a response. Historically, most live-attenuated vaccines have been the measles/mumps/rubella combined vaccine, chickenpox vaccine, and human influenza vaccine. Polio and hepatitis A are prevented with an inactivated vaccine.

Two new studies, led by scientist Luis Martinez-Sobrido, PhD, resulted in two of the first-ever live-attenuated vaccines for canine influenza, specifically for a strain called H3N8. Veterinarians have used inactivated vaccines for canine flu in the past, but the recent study results suggest that the live-attenuated vaccines are more effective and still very safe. Currently, the H3N8 strain is circulating in dogs in the United States.

Both studies used a genetic engineering technique called reverse genetics, a relatively new approach that, as its name suggests, works in the opposite direction of what many scientists would call “traditional” genetics. Instead of starting with a mutant phenotype and working toward identifying its DNA and protein sequence, a reverse genetics approach begins with recombinant DNA and works backward to identify a mutant phenotype.

The first of Martinez-Sobrido’s studies involved developing a live-attenuated vaccine that solely multiplied in the nose instead of in the lungs. This method was intended to “stop the virus in its tracks” once it made its first stop at the nose, allowing the immune system to wipe out the infection before it traveled to the rest of the body.

The second study removed an integral piece of the H3N8 canine influenza virus to obtain the desired effect of an immune response without the detrimental impact of an actual illness. The protein is called NS1, and past research led scientists to believe that separating it from the H3N8 strain would have this effect.

Both of the studies produced a vaccine candidate that proved to be safe and more effective than existing H3N8 vaccines, which researchers were able to show via tests in mice and in canine tracheal cells. As the research progresses, Martinez-Sobrido plans on beginning clinical trial with dogs, hoping that some day soon the new live-attenuated vaccine for this troublesome strain of canine influenza might be used on a larger level, starting with preventing the spread of disease in shelters and kennels.

The two studies were published in the Journal of Virology and the journal Virology.

Sources: BIO Ventures for Global Health, HistoryofVaccines.org, An Introduction to Genetic Analysis, 7th edition, University of Rochester Medical Center

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 07, 2021
Microbiology
Positive Results From A Clinical Trial of an HIV Vaccine
FEB 07, 2021
Positive Results From A Clinical Trial of an HIV Vaccine
After years of effort, researchers are reporting that there were encouraging results from a phase 1 clinical trial which ...
FEB 10, 2021
Drug Discovery & Development
Genetics Affect Response to Cancer Immunotherapy
FEB 10, 2021
Genetics Affect Response to Cancer Immunotherapy
Researchers have found that genetic factors may dictate as much as 20% of the efficacy of checkpoint inhibitors, a kind ...
MAR 04, 2021
Immunology
Why Do We Need Two Shots of the COVID Vaccine?
MAR 04, 2021
Why Do We Need Two Shots of the COVID Vaccine?
Unlike social distancing, mask-wearing, and hand hygiene, vaccines are our best bet as a long-term solution to protectin ...
MAR 18, 2021
Immunology
"Brainwashed" Immune Cells Help Breast Tumors Thrive
MAR 18, 2021
"Brainwashed" Immune Cells Help Breast Tumors Thrive
Immunologists have discovered a mechanism through which immune cells get recruited into breast cancer tumors, and instea ...
JUN 07, 2021
Health & Medicine
Higher Incidence of Breast Cancer in Polluted Urban Areas
JUN 07, 2021
Higher Incidence of Breast Cancer in Polluted Urban Areas
A Taiwanese study looked at the incidence of breast cancer in areas of Taiwan with varying levels of air pollutants. Air ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
Loading Comments...